CAS 5786-21-0
:Clozapine
- 5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-
- 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
- 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
- Apo-Clozapine
- Asaleptin
- Azaleptin
- Azaleptine
- Brn 0764984
- Ccris 9171
- Clorazil
- Cloril
- Clozapex
- Clozapin
- Clozapina
- Clozapina [INN-Spanish]
- Clozapinum
- Clozapinum [INN-Latin]
- Clozaril
- Fazaclo
- Fazaclo ODT
- Hf-1854
- Hsdb 6478
- Iprox
- Klozapol
- Leponex
- Lx 100-129
- Sizopin
- Unii-J60Ar2Ikic
- W-801
- Clozapine
- e)(1,4)diazepine,8-chloro-11-(4-methyl-1-piperazinyl)-5h-dibenzo(
- CLOZAPINE ATYPICAL NEUROLEPTIC
- LIPONEX
- Lepotex
- COLZARIL
- 8-chloro-11-(4-methyl-1-piperazinyl)-5h-dibenzo(e)(1,4)diazepine
- See more synonyms
Clozapine
CAS:Formula:C18H19ClN4Purity:>98.0%(GC)(T)Color and Shape:Light yellow to Amber to Dark green powder to crystalMolecular weight:326.83Clozapine, 97%
CAS:Potent, selective muscarinic antagonistFormula:C18H19Cl4Purity:97%Molecular weight:326.83Clozapine
CAS:ClozapineFormula:C18H19ClN4Purity:99.9%Color and Shape:Off-WhiteMolecular weight:326.12982CLOZAPINE FOR PEAK IDENTIFICATION CRS
CAS:CLOZAPINE FOR PEAK IDENTIFICATION CRSFormula:C18H19ClN4Molecular weight:326.8233Clozapine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C18H19ClN4Color and Shape:Yellow PowderMolecular weight:326.12982Clozapine Resolution Mixture
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureColor and Shape:Yellow Crystalline PowderMolecular weight:203.09061Clozapine
CAS:Clozapine (HF 1854) is a tricylic dibenzodiazepine, classified as an atypical antipsychotic agent.Formula:C18H19ClN4Purity:99.91% - 99.93%Color and Shape:Yellow Crystals From Acetone-Petroleum Ether SolidMolecular weight:326.82Ref: TM-T0455
10mg34.00€1mL*10mM (DMSO)44.00€25mg49.00€50mg66.00€100mg90.00€200mg161.00€500mg286.00€1g425.00€Clozapine
CAS:Formula:C18H19Cl4Purity:≤ 0.3%Color and Shape:Yellow crystalline powderMolecular weight:326.83Clozapine-d4 (4-methyl-piperazinyl-2,2,6,6-d4)
CAS:Purity:99 atom % DColor and Shape:Yellow SolidMolecular weight:330.85Clozapine
CAS:Controlled ProductApplications An antipsychotic.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Stille, et al: Farnaco, Ed. Prat., 26, 603 (1971), Hane, J.M., et al.: Psychopharmacol. Bull., 24, 62 (1988), Meltzer, H.Y.: J. Clin. Psychiatry, 55, Suppl. B, 47 (1994)Formula:C18H19ClN4Color and Shape:Off-WhiteMolecular weight:326.82Clozapine
CAS:Controlled ProductPartial 5-HT1A agonist; adrenergic, cholinergic, and histaminergic antagonistFormula:C18H19ClN4Purity:Min. 97.5 Area-%Color and Shape:Yellow PowderMolecular weight:326.82 g/molClozapine - Bio-X ™
CAS:Controlled ProductClozapine, a dibenzodiazepine, demonstrates antagonistic activity at the dopamine receptors, further binding to serotonin (5-HT1A, 5-HT2A-C, 5-HT6, 5-HT7), alpha 1 and 2 adrenergic, histamine 1 and M1-M5 muscarinic receptors. In particular, its partial 5-HT1A agonist behaviour, its low affinity for the D2 Dopamine receptors and its antagonistic activity at 5-HT2A receptors, are properties, which make it useful as an antipsychotic drug. The FDA has approved Clozapine for use in the alleviation of symptoms in treatment-resistant schizophrenia patients, such as the risk of self-harm. Although not yet approved by the FDA, Clozapione exerts positive effects in Parkinson’s disease and bipolar disorder treatments. However, Clozapione is not currently a first line-therapy option, as it may cause agranulocytosis and other side effects such as orthostatic hypotension and hypersalivation.
Formula:C18H19ClN4Purity:Min. 95%Color and Shape:Yellow PowderMolecular weight:326.82 g/mol5-Acetyl-8-chloro-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one
CAS:Formula:C15H11ClN2O2Color and Shape:NeatMolecular weight:286.713

















